Merck to disclose some education grants

Share this article:

Merck has announced plans to “enhance transparency” by disclosing certain grants to the public, a company statement said.

The move follows an announcement from Eli Lilly on Sept. 24 that the company will disclose physician payments through an online registry in 2009. 

Although Merck has endorsed congressional legislation (known as the Physician Payments Sunshine Act) which would mandate physician payment disclosure, the company's current plan will only reveal education grants—including accredited CME grants—to “patient organizations, medical professional societies and other organizations…by our Global Human Health division,” according to the statement. Grants will be posted to merck.com beginning in October.

Barring a legislative mandate, however, Merck will begin disclosing physician payments in 2009, and will expand grant disclosures made by two other divisions of the company, according to the statement. Additionally, Merck will continue to disclose results from registered trials of marketed products, regardless of outcome, the statement said.

Share this article:
You must be a registered member of MMM to post a comment.
close

Next Article in News

Email Newsletters

More in News

Five things for Pharma Marketers to know: Friday, August 29

Five things for Pharma Marketers to know: Friday, ...

Takeda closes out a good-news, bad-news kind of week, AstraZeneca adds a new clinical trial for its experimental PD-1, and researchers link a funeral to the Ebola outbreak.

Amgen sends PCSK9 to FDA

Amgen sends PCSK9 to FDA

Evolocumab holds the FDA's first filed biologics license application for the class.

Consultants expect M&A tempo to continue

Consultants expect M&A tempo to continue

PwC anticipates that divestitures will fuel late-2014 deals, but notes that the noise around early deals and the financials don't fully match up.